Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Protein farnesyltransferase inhibitor from Banyu and Merck & Co.

May 31, 1996

Walter Reed Army Institute technology licensed to Jenner Technologies

May 31, 1996

Sandoz reports complex for radiotherapy of somatostatin receptor-positive cancers

May 31, 1996

OC104-26 identified as multidrug resistance (MDR)-reversing agent

May 31, 1996

ISIS-7597, an antisense oligonucleotide, shows promise in battling multidrug resistance

May 31, 1996

A highly lipophilic delta7-PGAI analogue, TEI-9826, demonstrates antitumor activity

May 31, 1996

Sulfone metabolite of sulindac induces apoptosis

May 31, 1996

C225 shows absence of dose-limiting toxicity

May 31, 1996

ALRT-1057 exhibits high incidence of complete remission

May 31, 1996

U.S. Bioscience and Alza embark on marketing agreement for altretamine

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...